Aeon Biopharma Inc

CUSIP 00791X209CL A NEWAEONQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Oct 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Oct 14, 2025	Alta Partners LLC	13G/A	2.1%	24.99B	SEC
2	Jul 9, 2025	Alta Partners LLC	13G/A	5.2%	586.3K	SEC
3	May 30, 2025	Chernett Jorey	13G	10.0%	1.13M	SEC
4	Mar 10, 2025	Alta Partners LLC	13G	6.2%	629.6K	SEC
5	Mar 3, 2025	Dauntless Investment Group, LLC	13G	9.7%	108.2K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Dauntless Investment Group, LLC	2.53M	$2.49M
2	Geode Capital Management, LLC	87.1K	$85.8K
3	Blue Owl Capital Holdings LP	42.4K	$41.5K
4	Formidable Asset Management, LLC	20.0K	$22.0K
5	Xtx Topco Ltd	20.4K	$20.1K
6	Jane Street Group, LLC	16.4K	$16.1K
7	Lpl Financial LLC	11.5K	$11.3K
8	Ubs Group AG	4.2K	$4.1K
9	Blackrock, Inc.	2.8K	$2.8K
10	Steward Partners Investment Advisory, LLC	1.1K	$1.1K